Medela Gathers Top Lactation & Breastfeeding Experts from Around the World at Global Symposium
Leading Breast Pump Brand Hosts Virtual Event to Advance Breastfeeding Research & Improve Health Outcomes
Baar, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Medela, a leading breast pump brand and medical device manufacturer, today announced its 15th Global Breastfeeding and Lactation Symposium focusing on advancing lactation science to improve care will take place on Tuesday, September 21 and Wednesday, September 22, 2021. For the first time, this event will be virtual, taking place from 4 p.m. to 7 p.m. CET / 10 a.m. to 1 p.m. ET each day.
In its 15th year, the Global Breastfeeding and Lactation Symposium hosted by Medela will feature globally renowned experts in human milk and lactation to share their latest research findings and insights. This year, healthcare professionals in maternity and infant care around the world are encouraged to attend
- to advance lactation science and understanding around protecting human milk and breastfeeding in a COVID-19 world,
- progressing clinical standards of care for lactation, and
- translating evidence to practice to improve outcomes.
“The criticality of breastfeeding became increasingly evident through the pandemic, making the research shared at this Symposium even more important,” said Annette Brüls, CEO of Medela worldwide. “This unique event reflects our commitment to turning science into care and nurturing health for generations. We believe it’s essential to unite today’s leading experts with the passionate professionals in maternal and infant health to advance breastfeeding research and improve lactation care around the world.”
Breastfeeding is essential for infant short- and long-term health, preventing acute infections and programming lower risk for chronic disease. Despite the wealth of information on the benefits for mother and infant, breastfeeding rates remain low worldwide, at just 41%.1
“Translational research is essential in the field of human lactation if we are to engage science to solve the issues that breastfeeding women and their babies face,” explained Prof. Donna Geddes of The University of Western Australia. Amongst others, Professor Geddes will present her latest research review discussing using a biological systems approach to provide a holistic knowledge platform to achieve better health outcomes for the next generation at the Symposium.
The two-day virtual event includes talks and discussions from experts around the world presenting their latest research findings, including:
- DR. ROSALINA BARROSO (PRT) | Increasing the dose of own mother‘s milk in the NICU: A quality improvement approach
- PROF. LARS BODE (USA) | Safety evaluation of human milk at the onset of the COVID-19 pandemic
- DR. DANI DUMITRIU (USA) | The impact of COVID-19 on breastfeeding
- PROF. CHRISTOPH FUSCH (DEU) | Optimization of nutrient intake in the NICU
- PROF. DONNA GEDDES (AUS) | A 25-year journey in human lactation from discovery to translation
- HER EXCELLENCY TOYIN SARAKI (NGA) | The Sub-Saharan effect: COVID-19, maternal and neonatal health and the community-centered approaches to building back better
- PROF. PAULA MEIER (USA) | Initiation breast pump technology: Integrating clinical scholarship and basic science research; best practices for initiating lactation in the NICU
- DR. REBECCA POWELL (USA) | The protective effect of human milk against COVID-19
- KIMBERLY SEALS ALLERS (USA) | Understanding experiences of bias in hospital lactation support from African American and BIPOC women: Data from an 18-month study of the IRTH project
- PROF. DIANE SPATZ (USA) | A call to action: Ensuring coming to volume for all lactating parents
- PROF. SHUPING HAN (CHN) | Continuous quality improvement practices on human milk feeding of very low birth weight
- PROF. HANS VAN GOUDOEVER (NLD) | Recommendations for clinical practices to preserve and promote breastfeeding, now and in the future
Registration2 for the two-day event costs 60 EUR ($70 USD) . To ensure participation and strengthen accessibility, professionals from low-income countries and members of Non-Governmental Organisations that work for non-profit are invited to attend for no-cost access by following the instructions on the event website. Allocating all event fees and reinforced by Medela Cares funding, Medela has committed to supporting 60 Ronald McDonald House® locations around the world with breastfeeding supplies by the end of 2022, in honor of the company’s 60th anniversary. This donation will include a hospital-grade (multi-user) Symphony® breast pump, kits, and breastfeeding accessories for use by families with breastfeeding needs to ensure parents staying at a Ronald McDonald House® have one less thing to worry about.
Attendees will have access to live events and poster session on both days and direct interaction with industry experts and peers. All presentations will be available on demand through June 2022 and offered in English, Japanese, Chinese, and Spanish. For attendees in the USA and Canada, CE credits are available.
Learn more about the Global Breastfeeding and Lactation Symposium at medela.com/symposium. Follow the conversation on social media using #AdvancingBreastfeedingResearch.
Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. Medela is dedicated to building better health outcomes, simplifying and improving life, and developing breakthroughs that help moms, babies and patients live their life to the fullest. For more information, visit www.medela.com.
1 La Leche League International: 2021 World Health Day: Improve global breastfeeding practices. 2021 World Health Day: Improve global breastfeeding practices | La Leche League International (llli.org)
2 The registration fee is not a donation and is not tax deductible
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Gordon Brothers Names Karl Werner President, International Commercial & Industrial21.9.2021 15:00:00 CEST | Press release
Boston, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Gordon Brothers, the global advisory, restructuring and investment firm, has named Karl Werner President, International Commercial & Industrial. Werner, a former Ritchie Bros. executive, will join the senior leadership team to further develop and execute investment and disposition strategies across the firm’s International Commercial & Industrial practice. He and his team will partner with companies, their investors, lenders and advisors to overcome operational challenges, transform their businesses and dispose of assets. Werner comes to Gordon Brothers with an impressive 30-year track record in global asset management and disposition. He demonstrates innovative leadership in the commercial, industrial and auction industries where his teams have generated more than $1 billion in annual sales. “We are delighted to welcome Karl to Gordon Brothers,” said Frank Morton, CEO of International for Gordon Brothers. “He is a talented and consummate lead
Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably21.9.2021 12:17:09 CEST | Press release
To feed a growing population, Novozymes is inviting all interested parties to help co-create and innovate the future of sustainable protein. By combining science with business expertise Novozymes wants to rethink how protein is made and sourced by enabling a new and progressive industry to provide sustainable nutrition. COPENHAGEN, DENMARK – 21 September, 2021 – As the U.N. Food System Summit sets the stage to bring about tangible, positive changes to the world’s food systems, Novozymes, the world leader in biological solutions, wants to rethink the way we manufacture and source protein. Novozymes announces the launch of the Myco-protein Innovation Call – a global platform to cultivate new business collaborations to scale up the most promising innovations and ideas around how to use fungi as a source of protein. “Realizing the importance of rethinking how we expand the adoption of plant-based protein and how we meet an increasing demand for sustainable nutrition, Novozymes is launching
Biotalys to Participate in Upcoming Investor and Stakeholder Events21.9.2021 12:00:00 CEST | Press release
Ghent, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Press release Biotalysto Participate in Upcoming Investor and Stakeholder Events Ghent, BELGIUM – 21September2021– Biotalys (Euronext - BTLS), an AgTech company focused on addressing food protection challenges to enable a more sustainable and safer food supply, today announces that it will be presenting at the following events during the remainder of 2021: Bryan-Garnier Food Tech Virtual Conference, 23-24 September CEO Patrice Sellès and CFO Wim Ottevaere will be speaking at Bryan Garnier & Co.’s Food Tech Conference on Friday 24 September at 15:00 CEST to an international audience of investors, with a presentation and Q&A session. Knowledge for Growth (FlandersBio), 28 September Biotalys will give a company presentation and participate in a panel debate on Europe’s Farm to Fork strategy at Knowledge for Growth on Tuesday 28 September 2021, at 14:00 CEST. The conference takes place in Ghent and is attended by decision makers from the biotech, p
TGS Share Repurchase21.9.2021 11:11:02 CEST | Press release
Oslo, Norway (21 September 2021) – On period from 16 September 2021 to 20 September 2021, TGS ASA (TGS) purchased 60,000 own shares on the Oslo Stock Exchange at an average price of NOK 83.8969 per share. Following the purchase TGS 1,076,095 own shares, representing 0.917% of the total outstanding shares. The shares were purchased in connection with the share repurchase announced on 11 February 2021. Overview of transactionsDateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)16-Sep-2120,00087.38141,747,62817-Sep-2120,00083.70701,674,14020-Sep-2120,00080.60241,612,048Previously disclosed buy-backs under the program (accumulated)950,995109.5342104,166,514Accumulated under the buy-back program1,010,995108.0127109,200,330The issuer's holding of own shares:Following the completion of the above transactions, TGS owns a total of 1,076,095 own shares, corresponding to 0.917% of TGS' share capital.Appendix:An overview of all
RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS21.9.2021 11:07:00 CEST | Press release
RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS Auction date2021-09-21Loan2505 Coupon1.00 %ISIN-codeSE0011414010Maturity2025-05-12 Tendered volume, SEK mln1,250 +/- 650 Volume offered, SEK mln3,236Volume bought, SEK mln1,250 Number of bids7 Number of accepted bids3 Average yield0.194 %Lowest accepted yield0.190 %Highest yield0.197 %% accepted at lowest yield 83.33 Auction date2021-09-21Loan2611 Coupon1.00 %ISIN-codeSE0012569572Maturity2026-11-12 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln3,280 Volume bought, SEK mln1,250 Number of bids9Number of accepted bids6 Average yield0.417 %Lowest accepted yield0.415 %Highest yield0.424 %% accepted at lowest yield 77.00 Auction date2021-09-21Loan2805 Coupon0.75 %ISIN-codeSE0015660139Maturity2028-05-12 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln1.250Volume bought, SEK mln500 Number of bids3 Number of accepted bids1 Average yield0.608 %Lowest accepted yield0.608 %Highest yield0.608 %% accepted at lowest yie
RESULT OF RIKSBANK CERTIFICATE SALE21.9.2021 10:15:00 CEST | Press release
AuctionAuction resultsAuction date2021-09-21Start date2021-09-22Maturity date2021-09-29Interest rate, %0.00Offered volume, SEK bn526.0Total bid amount, SEK bn2466.173Accepted volume, SEK bn526.0Number of bids18Percentage alloted, %21.329
Mangold Insight presenterar ny analys om Terranets möjligheter21.9.2021 10:14:59 CEST | Pressemelding
I en ny analys upprepar Mangold Insight sin köprekommendation för Terranets aktie efter de senaste framstegen för företaget och med utgångspunkt i den höga aktiviteten i fordonsindustrin. Det expanderande teamet med ett högre kommersiellt fokus lyfts fram i kombination med den patenterade teknologin. Den livräddande VoxelFlow-tekniken kompletterar annan sensorteknologi i dagens fordon. Möjligheten att kunna klassificera och följa objekt upp till hundra gånger snabbare än branschstandarden är dess mest unika attribut, i kombination med den höga bildkvaliteten som teknologin genererar. Du hittar analysen "Snabbare Takt framåt" här: https://bit.ly/3nSsz55 För mer information om Terranet: Pär-Olof Johannesson Tel: +46 70 332 32 62 E-post: firstname.lastname@example.org Om Terranet Terranet (Nasdaq: TERRNT-B.ST). Med visionen att rädda liv utvecklar Terranet sensorteknologi för kollisionsvarning i trafiken. Bolaget levererar mjukvara med tillämningar för avancerat förarstöd och autonoma fo